Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma

• Ira J. Dunkel ,

  * E-mail: dunkeli@mskcc.org

  Affiliations Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America, Department of Pediatrics, New York Presbyterian Hospital Weill Cornell Medical College, New York, NY, United States of America

  ⨯
• Weiji Shi,

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America

  ⨯
• Kim Salvaggio,

  Affiliation Department of Neurosurgery, New York Presbyterian Hospital Weill Cornell Medical College, New York, NY, United States of America

  ⨯
• Brian P. Marr,

  Affiliations Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America, Department of Ophthalmology, New York Presbyterian Hospital Weill Cornell Medical College, New York, NY, United States of America

  ⨯
• Scott E. Brodie,

  Affiliation Department of Ophthalmology, Mount Sinai Medical Center, New York, NY, United States of America

  ⨯
• Y. Pierre Gobin,

  Affiliation Department of Neurosurgery, New York Presbyterian Hospital Weill Cornell Medical College, New York, NY, United States of America

  ⨯
• David H. Abramson

  Affiliations Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America, Department of Ophthalmology, New York Presbyterian Hospital Weill Cornell Medical College, New York, NY, United States of America

  ⨯